6.19
-0.03
(-0.48%)
At close: 5:50:14 PM GMT+3
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,715,456.44
2,715,456.44
2,210,435.35
1,795,432.75
1,427,218.37
Cost of Revenue
499,215.16
499,215.16
389,887.33
311,233.13
234,425.41
Gross Profit
2,216,241.28
2,216,241.28
1,820,548.02
1,484,199.62
1,192,792.97
Operating Expense
2,064,628.39
2,064,628.39
1,726,342.01
1,385,118.35
1,015,671.79
Operating Income
151,612.90
151,612.90
94,206.01
99,081.27
177,121.17
Net Non Operating Interest Income Expense
-98,226.28
-98,226.28
-77,525.78
-40,590.01
-27,266.19
Pretax Income
44,316.76
44,316.76
4,299.48
49,557.30
135,419.56
Tax Provision
25,959.98
25,959.98
8,464.34
12,124.75
22,506.35
Net Income Common Stockholders
25,545.59
25,545.59
3,684.29
32,173.07
102,613.93
Diluted NI Available to Com Stockholders
25,545.59
25,545.59
3,684.29
32,173.07
102,613.93
Basic EPS
0.05
--
0.01
0.06
0.19
Diluted EPS
0.05
--
0.01
0.06
0.19
Basic Average Shares
531,064.93
--
526,273.97
531,075.22
531,168.28
Diluted Average Shares
531,064.93
--
526,273.97
531,075.22
531,168.28
Total Operating Income as Reported
142,401.14
142,401.14
91,517.36
94,229.67
171,851.90
Rent Expense Supplemental
14,561.66
14,561.66
12,823.12
8,432.80
7,698.48
Total Expenses
2,563,843.54
2,563,843.54
2,116,229.34
1,696,351.48
1,250,097.20
Net Income from Continuing & Discontinued Operation
25,545.59
25,545.59
3,684.29
32,173.07
102,613.93
Normalized Income
33,283.47
33,283.47
5,942.76
35,837.67
107,007.46
Interest Income
2,482.53
2,482.53
3,423.08
1,261.84
149.94
Interest Expense
93,969.40
93,969.40
76,309.36
34,323.37
21,598.66
Net Interest Income
-98,226.28
-98,226.28
-77,525.78
-40,590.01
-27,266.19
EBIT
138,286.17
138,286.17
80,608.84
99,081.27
157,018.22
EBITDA
387,584.10
387,584.10
277,999.76
251,492.02
270,778.42
Reconciled Cost of Revenue
499,215.16
499,215.16
389,887.33
311,233.13
234,425.41
Reconciled Depreciation
249,297.94
249,297.94
197,390.92
152,410.75
113,760.20
Net Income from Continuing Operation Net Minority Interest
25,545.59
25,545.59
3,684.29
32,173.07
102,613.93
Total Unusual Items Excluding Goodwill
-9,211.76
-9,211.76
-2,688.65
-4,851.60
-5,269.27
Total Unusual Items
-9,211.76
-9,211.76
-2,688.65
-4,851.60
-5,269.27
Normalized EBITDA
396,795.86
396,795.86
280,688.41
256,343.62
276,047.68
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,473.88
-1,473.88
-430.18
-1,187
-875.74
12/31/2021 - 12/21/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FREA.F Fresenius SE & Co. KGaA
9.65
+5.46%
0H9X.IL Fresenius Medical Care AG
44.32
+1.54%
LKMNH.IS Lokman Hekim Engürüsag Saglik, Turizm, Egitim Hizmetleri ve Insaat Taahhüt A.S.
17.84
+0.22%
RMSYF Ramsay Health Care Limited
20.34
0.00%
0286.HK AIDIGONG
1.320
0.00%
6H90.MU Healwell AI Inc
0.8835
-0.90%
6MA.F Ambea AB (publ)
9.89
+6.69%
TRL.F DaVita Inc.
132.20
+0.27%
MPARK.IS MLP Saglik Hizmetleri A.S.
310.00
+0.49%
Q0F.SI IHH Healthcare Berhad
2.0100
-0.50%